Straws are discrete research notes that relate to a particular aspect of the company. Grouped under #hashtags, they are ranked by votes.
A good Straw offers a clear and concise perspective on the company and its prospects.
Please visit the forums tab for general discussion.
Selling Oct 2024 - Have grown uncomfortable with the governance of the company over the past month. Whilst I knew Jamie Pherous was a strong and entrepreneurial Founder CEO I had hoped the Board would offset and oversee that. Having seen the proposals at this AGM, especially the size of the Board fee pool increase and justification given, I am not sure we don't have a Board that's just "along for the ride". Given the blow ups playing out at WTC and MIN right now, who also have very strong Founder CEO's, it's a risk or hurdle that might now be too high. I could be wrong of course but it's foreseeable problem right now, so I am OK to swap for a better option. I will still prioritise Founder led businesses but their personalities and Boards are also part of that equation.
Updated Valuation in Aug 2024 based on 69.5 cents EPS for FY24 and 10% growth rate for next 10 years (less than half historical average) with PE of 18 (bottom decile of historical average).
Why do I own it?
# Top 5 global player in the travel industry focused on government and corporate clients. These customers are less likely to want to manage their own travel needs and often are on contracts. Business is nicely diversified with 50% in US, 25% ANZ, 20% EU and 5% Asia.
# Was badly impacted by Covid travel restrictions and sales/profits were smashed, which has caused negative sentiment over the past few years. Prior to Covid the business was compounding earnings at over 25% p.a. and has now returned to a higher EPS number in FY24 than pre Covid.
# Has a strong and entrepreneurial founder in Jamie Pheros running the business who owns 12% of the shares. Small Board and all have a little skin in the game too.
# Have somewhat of a trap door moat, as the hassles of switching providers and systems can be painful for governments and large corporates.
# Debt to equity ratio of only 3%. ROE / ROC is improving and should be back around 15% at the end of FY25. Net margins are now 14% and should be back at around 20% at the end of FY25.
# Big MOS at current price of $11.40 in Aug 2024 at less than half the historical growth rate. They have been buying back shares consistently in FY24, and announced up to $100 million in additional buybacks for FY25, indicating they believe there is significant upside.
# They can deliver double digit revenue and earnings growth for 5 + years so the return should exceed my 15%p.a. + target. They released a growth plan at the beginning of 2024 with the path to double earnings over the next 5 years.
What to watch
# Significant key person risk if something was to happen to Jamie Pheros - need to see who the possible successors are.
# Jamie can be "glass half full" with guidance, so need to follow actual results and not forecasts. He also has little time for analysts.
# They do "project" work at times for governments like war or asylum seeker transport etc which is high margin but very sporadic. This can cause some lumpiness in business from one year to the next. Need to follow the core business trends and take these project wins when they come as exceptions.
# Are vulnerable to black swan events that restrict global travel - want to see ongoing healthy balance sheets.
# Have acquired other travel players over the years - want to make sure they don't overpay or over extend with any future acquisitions.
https://cdn-api.markitdigital.com/apiman-gateway/CommSec/commsec-node-api/1.0/event/document/1410-02840758-5J13BAVE4OP0HQPOG8J9UU2V4G/pdf?access_token=0007ElapJLU3ePdTI2LQFuXW6ucp
CTD is described by Simply Wall St as a « Big Green Snowflake ». Growing, dividend. But the market hates it. There was an earnings miss a few months ago that the market punished the stock for. There were two issues: a UK contract miss (guidance assumed zero earnings from it after the downgrade) and variance in US corporate travel spend. But the web traffic suggests consistent uplift. In contrast to stocks like KGN and AD8 where web traffic has dropped off a cliff (probably more relevant to KGN).
Shorts for CTD are 5% - what is the short thesis? Europe conflict? Pandemic? Other?
https://www.tipranks.com/stocks/au:ctd/forecast
Ewen Crouch just purchased ~20k on market @15.08. Seems he agrees they’re value at this price
Is this all just in the back of Middle East tensions? It seems corporate travel at a PE or less than 20 is a pretty good opportunity…?
CTD was smashed on Thursday after releasing half year results.
Full year results were expected to double NPAT. Announced on Thursday that full year expected to be $40m less due to weaker December and a UK contract that didn’t yield expected revenue (I think the UK is a bit of a basket case atm for a few co’s).
Reported January showed more promise.
For a still growing company paying a dividend, a forward PE of under 20 and a chart that looks like this (taking into account COVID), I think it’s worth a look
CTD reported today.
Share price has been smashed - down 18% at time of writing.
Result was a bit disappointing but the correction is overdone in my view.
The background here is that CTD grew very strongly until COVID hit and the travel industry got hit hard. CTD made a big US acquisition at that time, which good companies do when competitors struggle. CTD were able to do that because they had such a strong run leading up to COVID.
Of course, their results in COVID got hit and they are still recovering.
The share price correction is a reaction to the results not returning as quickly as the market would like.
1H24 result
As you can see these are strong numbers.
Full year result has been downgraded for the following reasons
Full year underlying NPAT is being revised down to $125-$140M. FY23 was $92M.
So we are still talking full year result of +30% for a company on current P/E of 28. Forward P/E will be about 19.
Looking at it another way. Full year result will take EPS back to 2019 levels when the share price varied from $19 - $33. At time of writing it is $16.
Had an interesting meeting yesterday where this came up - not a company I know much about at all but there were some strong views. Not sure if this is common knowledge or not - nor have i quantified it by actually looking at CTD.
From what I understand most of their most lucrative contracts and profits has come from government contracts. Think the repatriation flights from Israel currently (coordinating Qatar/Qantas/Emirates for Australian citizens) and the ongoing work in transporting and housing refugees to the UK - Fallout looms for Corporate Travel over Bibby Stockholm UK asylum barge contract (afr.com)
Essentially a reason they did so well during COVID and avoided a cap raise (unlike FLT and WEB) was not the narrative they did essential business travel - it was all the COVID repatriation flights that they must make massive margins on (though not disclosed for obvious reasons).
In short the narrative for this stock I think has been wrong for years - the government repatriation and other special flights are a big driver of profits - not typical business travel. This is not what they told the market of course.
Explains the empty locations and discrepancy in the financials form what they say they do that was in the short report years ago etc. As long as you think these government contracts continue then profit should continue but don't think the big driver is business travel.
Valuation is hard. At $21.60 the P/E is 92! However, forecast PBTA is $120-140 before the big contract announced. Let's ignore that since not long before EOY. A PBTA of $120-140 compares to last years ttm NPAT of about $30m. How big is the jump in profit? Depends on how much tax and amortisation they have.
I'm going to punt with $21 (just below the current share price) since surely NPAT will double from $30m to $60m bringing the P/E down to a more reasonable (but not cheap) 46. BUT there is high degree of uncertainty.